DeepCura vs Marvix AI (2026)
Two mid market products that reach well past the note, and they differ in what they disclose about it. DeepCura runs eight named agents covering pre visit history, documentation, diagnosis mapping, allergy reconciliation, order generation and billing, with per field write back, the most complete published pricing in this part of the category and a business associate agreement offered to all covered entities. Marvix builds for specialty care specifically, long consults and complex histories rather than the fifteen minute visit, with named two way integrations and a stated technical approach. Marvix fits the work better for a specialty group. DeepCura publishes more of what a buyer needs to evaluate. Neither publishes a confidence threshold or an accuracy figure for the agents that generate orders and codes, which is what a pilot should measure.
- It publishes the most complete pricing ladder in this part of the category and offers a business associate agreement to all covered entities rather than gating it.
- Eight named agents with defined scopes and per field write back is a clearer account of what each part does than a single assistant claim.
- The deployment question is answered by name rather than left open, which is more than most agent suites disclose.
- It is built for specialty care rather than the short primary care visit, aimed at long consults and complex longitudinal histories with a very large stated specialty range.
- Integrations are named, broad and genuinely two way rather than described as compatibility.
- It names its techniques rather than gesturing at them, and its coding path is more transparent than most at this size.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepCura and Marvix AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DeepCura | Marvix AI |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2023 | 2023 |
| Headquarters | Not recorded | Boston, Massachusetts |
| Website | deepcura.com | marvix.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
DeepCura is an all in one clinical automation platform built around eight named agents rather than a single scribe: pre visit history, ambient documentation, diagnosis mapping to ICD-10 and SNOMED, allergy reconciliation, order generation covering labs, imaging, durable medical equipment and prescriptions, billing with CPT codes linked to diagnoses, referrals including prior authorization, and follow up scheduling, alongside a 24/7 AI receptionist, patient intake and a unified fax, email, phone and SMS hub.
Source: AI Health Index, August 2026
Marvix AI is a Boston-based clinical documentation platform built for specialty care rather than the short general outpatient visit most scribes assume, targeting long consults, complex histories and longitudinal care across neurology, oncology, orthopedics, nephrology, psychiatry and pediatrics, with a claimed 135 or more specialties and subspecialties.
Source: AI Health Index, August 2026
Questions buyers ask
What evidence is published for DeepCura and Marvix AI?
For DeepCura, no study, controlled evaluation, accuracy benchmark, clinical outcome data or named health system deployment.
With Marvix AI, the vendor publishes specialty depth and product detail rather than outcomes, and the 30-day trial including full features and integration is a commercial term rather than evidence. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How much do DeepCura and Marvix AI leave to the clinician?
In DeepCura's case, no agent has a published confidence threshold, accuracy rate, abstention behavior or review gate.
The privacy policy states that outputs are drafts, that they are designed to require review, validation and affirmative acceptance by a licensed healthcare professional before clinical, billing or disclosure use, and that Marvix does not automate the signing, locking or finalization of clinical notes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Both take autonomous action beyond documentation, including diagnosis mapping, order generation and billing in one case and coding capture in the other, and neither publishes a confidence threshold, escalation behavior or accuracy figure for any of it. Read DeepCura's security wording carefully, since it describes itself in language implying an attestation it has not evidenced; ask for the report and its type. Marvix publishes no rate card, hosting region or residency option and no study or named deployment. Both market improved coding capture, so ask each for its add to delete ratio.